|
HLD-0117 Clinical Trials
1 actively recruiting trial across 1 location
No change since July 2026
Pipeline
Phase 1: 1
Top Sponsors
- Janssen Research & Development, LLC1
Indications
- Metastatic Breast Cancer1
- Breast Cancer1
- Cancer1
New Haven, Connecticut1 trial
A Study of HLD-0117 in Patients With Metastatic Breast Cancer
Yale- New Haven Hospital- Yale Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.